...
首页> 外文期刊>Journal of immunotherapy >Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.
【24h】

Cytokine-inducing activity and antitumor effect of a liposome-incorporated interferon-gamma-inducing molecule derived from OK-432, a streptococcal preparation.

机译:衍生自链球菌制剂OK-432的掺有脂质体的干扰素-γ诱导分子的细胞因子诱导活性和抗肿瘤作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

An interferon-gamma (IFN-gamma)-inducing molecule (OK-PSA) has been purified from OK-432 by an affinity chromatographic technique performed on cyanogen bromide-activated Sepharose 4B-bound TS-2 monoclonal antibody, which neutralizes IFN-gamma-inducing activity of OK-432. OK-PSA has striking anti-tumor activity in vivo and in vitro. In the current study, the liposomes were used to improve the delivery of the agent (OK-PSA) to effector cells and to increase the therapeutic effect. Significantly less OK-PSA encapsulated into liposomes (Lipo-OK-PSA) than OK-PSA alone (1/100 or less of OK-PSA alone) was required to induce IFN-gamma, tumor necrosis factor-alpha (TNF-alpha), TNF-beta, interleukin-1 beta (IL-1 beta), natural killer, and lymphokine-activated killer activities by human peripheral blood mononuclear cells and mouse spleen cells. Furthermore, higher levels of these activities were detected in peripheral blood mononuclear cells and mouse spleen cells treated with Lipo-OK-PSA than in those treated with OK-PSA. All of these activities induced by Lipo-OK-PSA were almost completely neutralized by anti-asialo-GM1 antibody and complement (p < 0.001). In in vivo experiments, Lipo-OK-PSA elicited striking anti-tumor activity on syngeneic Meth-A tumor-bearing and colon 26-bearing BALB/c mice and on salivary gland tumor-bearing nude mice far better than did OK-PSA. Furthermore, high levels of natural killer and lymphokine-activated killer activities and a significant increase in the number of cells positive for asialo-GM1, IFN-gamma, TNF-alpha, or IL-1 beta were detected in the spleen cells derived from the animals given Lipo-OK-PSA compared with those given saline. These findings clearly indicate that OK-PSA plays an important role in the anti-tumor efficiency of OK-432, and that, for the most part, liposome encapsulation of this molecule markedly accelerates its effect mediated by asialo-GM1-positive cells (mainly natural killer cells).
机译:干扰素-γ(IFN-γ)诱导分子(OK-PSA)已通过对溴化氰激活的琼脂糖4B结合的TS-2单克隆抗体进行亲和层析技术从OK-432纯化,该抗体可中和IFN-γ -OK-432的诱导活性。 OK-PSA在体内和体外均具有惊人的抗肿瘤活性。在当前的研究中,脂质体用于改善药剂(OK-PSA)向效应细胞的传递并提高治疗效果。诱导IFN-γ,肿瘤坏死因子-α(TNF-α)所需的OK-PSA封装在脂质体(Lipo-OK-PSA)中的数量明显少于单独的OK-PSA(单独的OK-PSA的1/100或更少) ,TNF-beta,白介素-1 beta(IL-1 beta),自然杀伤剂和淋巴因子激活的杀伤活性被人外周血单核细胞和小鼠脾细胞所破坏。此外,在用Lipo-OK-PSA处理的外周血单核细胞和小鼠脾细胞中检测到的这些活性水平高于在用OK-PSA处理的外周血单个核细胞和小鼠脾细胞中的水平。由Lipo-OK-PSA诱导的所有这些活性几乎都被抗ASF1 GM1抗体和补体完全中和(p <0.001)。在体内实验中,Lipo-OK-PSA对同系的Meth-A荷瘤和结肠26的BALB / c小鼠以及唾液腺荷瘤的裸鼠产生了显着的抗肿瘤活性,远优于OK-PSA。此外,在来源于小鼠的脾脏细胞中检测到高水平的自然杀伤和淋巴因子激活的杀伤活性,以及​​去唾液酸-GM1,IFN-γ,TNF-α或IL-1β阳性的细胞数量显着增加。给予Lipo-OK-PSA的动物与给予盐水的动物相比。这些发现清楚地表明,OK-PSA在OK-432的抗肿瘤功效中起着重要作用,并且在大多数情况下,该分子的脂质体封装显着加速了去唾液酸-GM1阳性细胞介导的作用(主要是自然杀伤细胞)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号